Question 1

What are the potential side effects of Rifapentine compared to the standard treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

Question 2

How will my eligibility for this trial be determined?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the treatment schedule look like if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

Question 4

How will this trial impact my overall treatment plan for LTBI?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

Question 5

What are the follow-up procedures after treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI clinical trial (NCT03474029). Contact the study team or your healthcare provider for specific answers.

What this study is about